Recent advances in PEG–PLA block copolymer nanoparticles

RZ **ao, ZW Zeng, GL Zhou, JJ Wang… - International journal …, 2010 - Taylor & Francis
Due to their small particle size and large and modifiable surface, nanoparticles have unique
advantages compared with other drug carriers. As a research focus in recent years …

Biodegradable diblock copolymeric PEG-PCL nanoparticles: Synthesis, characterization and applications as anticancer drug delivery agents

A Behl, VS Parmar, S Malhotra, AK Chhillar - Polymer, 2020 - Elsevier
Poly (ethylene glycol) methyl ether-block-poly (Ɛ-caprolactone) copolymers are useful
biomedical materials owing to their amphiphilic nature, biodegradability, biocompatibility …

Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery

ZS Bayindir, N Yuksel - Journal of pharmaceutical sciences, 2010 - Elsevier
Nonionic surfactant based vesicles (niosomes) are novel drug delivery systems formed from
the self‐assembly of nonionic amphiphiles in aqueous media. In the present study niosomal …

Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination

MC Chen, SF Huang, KY Lai, MH Ling - Biomaterials, 2013 - Elsevier
This study introduces a microneedle transdermal delivery system, composed of embeddable
chitosan microneedles and a poly (l-lactide-co-d, l-lactide)(PLA) supporting array, for …

Thermoreversible Pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake …

S Nie, WLW Hsiao, W Pan, Z Yang - International journal of …, 2011 - Taylor & Francis
Purpose To develop an in situ gel system comprising liposome-containing paclitaxel (PTX)
dispersed within the thermoreversible gel (Pluronic® F127 gel) for controlled release and …

Accelerated in-vitro release testing methods for extended-release parenteral dosage forms

J Shen, DJ Burgess - Journal of Pharmacy and Pharmacology, 2012 - academic.oup.com
Objectives This review highlights current methods and strategies for accelerated in-vitro
drug release testing of extended-release parenteral dosage forms such as polymeric …

Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors

G Bajaj, MR Kim, SI Mohammed, Y Yeo - Journal of controlled release, 2012 - Elsevier
Intraperitoneal (IP) chemotherapy is an effective way of treating local and regional
malignancies confined in the peritoneal cavity such as ovarian cancer. However, a …

Multifunctional materials for bone cancer treatment

C Marques, JMF Ferreira, E Andronescu… - International journal …, 2014 - Taylor & Francis
The purpose of this review is to present the most recent findings in bone tissue engineering.
Special attention is given to multifunctional materials based on collagen and collagen …

κ-Carrageenan hydrogel nanocomposites with release behavior mediated by morphological distinct Au nanofillers

AM Salgueiro, AL Daniel-da-Silva, S Fateixa… - Carbohydrate …, 2013 - Elsevier
In this work we investigate the effect of spherical and rod-shaped Au nanoparticles (NPs) in
the microstructure, thermomechanical and release properties of thermosensitive κ …

Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent

L De Smet, W Ceelen, JP Remon… - The Scientific World …, 2013 - Wiley Online Library
Intraperitoneal (IP) chemotherapy is an effective way of treating peritoneal carcinomatosis of
colorectal origin after complete cytoreduction. Although IP therapy has been already …